Nortriptyline (Nortriptyline Hydrochloride)

• Nortriptyline is used in the management of several conditions involving mood regulation and pain pathways.
• Major depressive disorder: alleviates depressive symptoms by enhancing neurotransmitter activity.
• Neuropathic pain: reduces pain intensity through modulation of central pain pathways.
• Migraine prophylaxis: decreases frequency and severity of migraine attacks when used as preventive therapy.

• Nortriptyline inhibits the neuronal reuptake of norepinephrine and serotonin, leading to increased concentrations of these neurotransmitters in the synaptic cleft. By blocking the presynaptic transporters, it prolongs neurotransmitter signaling in central nervous system pathways that modulate mood, pain perception, and vascular tone. The drug also exhibits antagonistic activity at certain muscarinic, histamine H1, and α1‑adrenergic receptors, contributing to its pharmacological profile.

Nortriptyline may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Dry mouth: reduced salivation leading to discomfort.
• Drowsiness: increased sedation, especially at treatment initiation.
• Constipation: slowed gastrointestinal motility.
• Weight gain: increased appetite or metabolic changes.
• Blurred vision: transient visual disturbances.
• Orthostatic hypotension: dizziness upon standing.

Serious or Rare Side Effects

• Cardiac arrhythmias: irregular heart rhythm, especially in overdose.
• Seizures: heightened risk in susceptible individuals.
• Severe hypotension: marked drop in blood pressure.
• Hepatotoxicity: liver enzyme elevations or injury.
• Serotonin syndrome: potentially life‑threatening reaction when combined with other serotonergic agents.
• Agranulocytosis: dangerously low white blood cell count.

Before prescribing nortriptyline, clinicians should consider several safety precautions.

• Assess cardiac history: evaluate for conduction abnormalities or recent myocardial infarction.
• Review psychiatric profile: monitor for worsening depression or emergence of suicidal thoughts.
• Check hepatic and renal function: dose may need adjustment in impairment.
• Avoid abrupt discontinuation: taper gradually to reduce withdrawal symptoms.
• Caution in elderly: increased sensitivity to anticholinergic effects and orthostatic hypotension.
• Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Nortriptyline can interact with various medicines, altering its efficacy or safety.

Major Interactions (Avoid)

• MAO inhibitors: concurrent use can cause hypertensive crisis or serotonin syndrome.
• SSRIs or SNRIs: increased risk of serotonin syndrome.
• Certain antiarrhythmics (e.g., quinidine): may lead to cardiac conduction disturbances.

Moderate Interactions (Monitor Closely)

• Anticholinergic drugs: additive dry mouth, constipation, urinary retention.
• CNS depressants (e.g., benzodiazepines, alcohol): enhanced sedation and respiratory depression.
• CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise nortriptyline plasma levels.